Session TitleRecent Advanced in 3D Printing and Bioprinting for Medical Applications
Session CodeSP-T15-0483
Date & Time / RoomMay 27 (Mon) 13:00~16:00 / Room 211
Organizer
Roger Narayan (UNC/NCSU Joint Department of Biomedical Engineering, USA)
Co-organizer
Roger Narayan (UNC/NCSU Joint Department of Biomedical Engineering, USA)
Chair
Roger Narayan (UNC/NCSU Joint Department of Biomedical Engineering, USA)
Jinah Jang (Pohang University of Science and Technology, Korea, Republic of)
Invited Speaker
Wei Sun (Drexel University and Tsinghua University, China)
Wei Sun (Drexel University and Tsinghua University, China)
Dr. Sun Wei, a young researcher at State Key Laboratory for Modification of Chemical Fibers and Polymer Materials, College of Materials Science and Engineering, Donghua University. He obtained his Ph.D. from Tongji University in 2019 under the supervision of Professor Wu Guangming. He joined Donghua University in October 2019 and his main research areas include the design and construction of functional conductive elastic materials, and 3D printing of biomaterials for medical applications. He has published a total of 25 SCI papers, with 15 papers as the first author/corresponding author in international academic journals such as ACS Nano, Theranostics, J. Mater. Chem. A, Adv. Electron. Mater., etc. One of his papers has been highly cited according to ESI. He has filed 7 invention patents in China, 5 of which have been granted. He is the principal investigator for 1 National Natural Science Foundation of China (NSFC) Young Scientist Fund, 2 sub-projects of the Ministry of Science and Technology's key research and development program, and 1 collaborative project with industry.
James Yoo (Wake Forest Institute for Regenerative Medicine, USA)
Jinah Jang (Pohang University of Science and Technology, Korea, Republic of)
Roger Narayan (UNC/NCSU Joint Department of Biomedical Engineering, USA)
Jinye Wang (Shanghai Jiao Tong University, China)
Jinye Wang (Shanghai Jiao Tong University, China)
Prof. Jin-Ye Wang, Ph.D (Tohoku University, Japan, 1992).
Professor of Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences (2000-2009); Professor of Biomedical Engineering, Shanghai Jiao Tong University (2009-).
Published 140 papers and 6 books (chapters); authorized 20 patents; invited speaker of European Conference on Biomaterials, Pacifichem et al.; awarded Hundred Talent Program of the Chinese Academy of Sciences (1999), Life Sciences Prize from Meiji Dairies Corporation (2008) et al.
Research interests: 3D Bioprinting, Tissue Engineering, Controlled Release, Biomimetic Materials and Biointerfaces.
Selected Publications (2020-):
1. Lin, Y.F., Yu, J.W., Zhang, Y.B., Hayat, H., Liu, C., Huang, X.Y., Lin, H.D.* and Wang, J.Y.* 4D Printed Tri-segment Nerve Conduit Using Zein Gel as the Ink for Repair of Rat Sciatic Nerve Large Defect. (2023) Biomaterial Advance, 151, 213473. 10.1016/j.bioadv.2023.213473
2. Hayat, H., Liu, C., Raza, A., Jingli Hou, J., Jia, C. and Wang, J.Y.* In vitro/in vivo identification of zein degraded peptides using HPLC-MS/MS and their safety evaluation. (2023) Biomedical Materials, 18, 025007. https://iopscience.iop.org/article/10.1088/1748-605X/acb411
3. Zhang,Y., Xue, Y., Ogawa, T., Wada, S. and Wang, J.Y.* 3D Printed Alginate Hydrogels with Stiffness-Gradient Structure in a Carbomer Supporting Bath by Controlled Ca2+ Diffusion. (2023) ACS Applied Engineering Materials, 1, 802-812. https://pubs.acs.org/doi/10.1021/acsaenm.2c00218
4. Jia, C.W., Zhang, Y.C., Wang, Y.Y., Gao, J.N., Raza, A., Ogawa, T., Wada, S., Xie, D. and Wang, J.Y.* Positively charged and neutral drug-loaded liposomes as the aerosolized formulations for the efficacy assessment of tumor metastases to lungs. (2023) Journal of Drug Delivery Science and Technology, 80, 104081. https://www.sciencedirect.com/science/article/pii/S1773224722009923
5. Zhang, Y.B., Raza, A., Xue, Y.Q., Yang, G.G., Hayat, U., Yu, J.W., Liu, C., Wang, H.J. and Wang, J.Y.* Water-responsive 4D printing based on self-assembly of hydrophobic protein “Zein” for the control of degradation rate and drug release. (2023) Bioactive Materials, 23, 343-352.
6. Raza, A., Zhang, Y.B., Uzma, H., Song, J.L., Shen, N.A., Chao, Y., Wang, H.J.* and Wang, J.Y.* Injectable zein gel with in situ self-assembly as hemostatic material. (2023) Biomaterial Advance, 145, 213225.
7. Xue, Y.Q., Zhang, Y.C., Zhang, Y.B. and Wang, J.Y.* Zein-based 3D Vascularized Scaffolds with Tunable Porosity for 3D Cell Culture and Drug Delivery. (2023) Biomedical Engineering Advances,5, 100059. https://www.sciencedirect.com/science/article/pii/S2667099222000354
8. Raza, A., Uzma, H., Zhang, X.H. and Wang, J.Y.* Self-assembled zein organogels as in situ forming implant drug delivery system and 3D printing ink. (2022) International Journal of Pharmaceutics, 627, 122206.
9. Li, J., Zhou, Y., Xu, J., Gao, F., Si, Q., Wang, J.Y., Zhang, F. and Wang, L.P.* Water-Soluble and Degradable Gelatin/Polyaniline Assemblies with High Photothermal Conversion Efficiency for pH Switchable Precise Photothermal Therapy. (2022)ACS Applied Materials & Interfaces, 14, 52670-52683.
10. Liu, C., Uzma, H., Raza, A., Jia, C.W. and Wang, J.Y.* Zein-based injectable biomaterial and angiogenic activity through peptides produced by enzymatic degradation. (2022) Journal of Drug Delivery Science and Technology, 78, 103937.
11. Zhang, Y.B., Wang, H.J., Raza, A., Liu, C., Yu, J.W. and and Wang, J.Y.* Preparation and evaluation of chitosan/polyvinylpyrrolidone/zein composite hemostatic sponges. (2022) International Journal of Biological Macromolecules. 205, 110-117.
12. Uzma, H., Raza, A., Bilal, M.N. lqbal, H.M.N* and Wang, J.Y.* Biodegradable polymeric conduits: Platform materials for guided nerve regeneration and vascular tissue engineering. (2022) Journal of Drug Delivery Science and Technology, 67, 103014.
13. Liu, C., Yang, H., Shen, N.A., Li, J.H., Chen, Y.S. and Wang, J.Y.* Improvement of Mechanical Properties of Zein Porous Scaffold by Quenching/Electrospun Fiber Reinforcement. (2021) Biomedical Materials, 16, 065016.
14. Wang, H.J.*, Mao, Q.Y., Feng, G., Liu, C., Yang, M.Z., Hao, M.F., Meng, Z.F., Li, S.M., Zhang, Y.P. and Wang, J.Y.* 3D printing of multi-functional artificial conduits against acute thrombosis and clinical infection. (2022) Composites Part B-Engineering, 230, 109497.
15. Yu, J.W., Wang, G.W., Lin, Y.F., Song, J.L., Hayat, U., Liu, C., Raza, A., Wu, W.F., Lin, H.D. and Wang, J.Y.* Zein-induced immune response and modulation by size, pore structure and drug-loading: Application for sciatic nerve regeneration. (2022) Acta Biomaterialia, 140, 289-301.
16. Wang, L.P., Wang, H.J., Hou, X.S., Raza A. and Wang, J.Y.* Preparation of stretchable composite film and its application in skin burn repair. (2021) Journal of the Mechanical Behavior of Biomedical Materials, 113, 104114.
17. Shen, N.A., Zhang, Y. and Wang, J.Y.* A parallel plate flow chamber device for evaluation of cell retention of electrospun zein fiber film under steady shear. (2021) Journal of Shanghai Jiaotong University (Sci), 26 (1), 69-75.
18. Shen, N.A., Zhang, Y. and Wang, J.Y.* Effects of the micro/nanostructure of electrospun zein fibres on cells in a fluid environment. (2021) Materials Science and Engineering C, 122, 111900.
19. Hou X.S., Zhou Y., Liu Y.J., Wang L.P.*, Wang J.Y. Coaxial electrospun flexible PANI//PU fibers as highly sensitive pH wearable sensor. (2020) Journal of Material Science, 55(33), 16033-16047.
20. Raza, A., Uzma, H., Bilal, M., lqbal, H.M.N* and Wang, J.Y.* Zein-based micro- and nano- constructs and biologically therapeutic cues with multi-functionalities for oral drug delivery systems. (2020) Journal of Drug Delivery Science and Technology, 58, 101818.
21. Uzma, H, Raza, A. and Wang, J.Y.* Preparation of Zein/PVP based conduits with tunable degradation. (2020) Polymer Degradation and Stability, 181, 109303.
22. Raza, A., Uzma, H., Wang, H.J. and Wang, J.Y.* Preparation and evaluation of captopril loaded gastro-retentive zein based porous floating tablets. (2020) International Journal of Pharmaceutics, 579, 119185.
23. Uzma, H., Raza, A., Wang, H.J.* and Wang, J.Y.* Preparation of ciprofloxacin loaded zein conduits with good mechanical properties and antibacterial activity. (2020) Materials Science and Engineering C, 111, 110766.
Description
Introductory abstract of a maximum of 300 words that addresses the symposium’s
1) objectives or purposes;
2) Proposed program and intended audience
3) expected outcomes and relevance to the main topic of WBC 2024.
Keywords : 3D Printing, Bioprinting
Session TrackWorkshop
Session TitleBiomaterials Science Excellence and Technology Translation
Session CodeSP-T15-0484
Date & Time / RoomMay 27 (Mon) 16:00~19:00 / Room 211
Organizer
Bingyun Li (West Virginia University School of Medicine, USA)
Chair
Jian Yang (Westlake University, China)
Jian Yang (Westlake University, China)
Dr. Jian Yang is currently a Chair Professor in Biomaterials and Regenerative Engineering, the chair of Biomedical Engineering Program, and an Associate Vice President at the Westlake University. Prior to Westlake, he was a Professor of Biomedical Engineering and Dorothy Foehr Huck and J. Lloyd Huck Chair in Regenerative Engineering at the Pennsylvania State University. Dr. Yang is known for his pioneering contribution on citrate chemistry and biology for the development and applications of citrate-based biomaterials. He was a recipient of NSF CAREER Award (2010), Outstanding Young Engineering Faculty Award at UTA (2011), PSEAS Outstanding Research Award at Penn State (2018), and BMES Wallace H. Coulter Award for Healthcare Innovation Award (2023). Dr. Yang is an elected Fellow of American Institute of Medical and Biological Engineering (AIMBE, 2016), the National Academy of Inventors (NAI, 2018), the Biomedical Engineering Society (BMES, 2020), the American Association for the Advancement of Science (AAAS, 2021), and the International Academy of Medical and Biological Engineering (IAMBE, 2023). Dr. Yang is the Co-Editor-in-Chief of “Bioactive Materials”, and an Associate Editor of “Science Advances”. Dr. Yang is a co-founder and the Past-President of Chinese Association for Biomaterials (CAB) and the recipient of 2023 CAB Distinguished Leadership and Service Award. Dr. Yang co-founded a medical device company, Aleo BME, Inc. and is also serving on the Scientific Advisory Board of Acuitive Technologies, LLC.
Kelvin Yeung (The University of Hong Kong, Hong Kong SAR, China)
Invited Speaker
William Wagner (University of Pittsburgh, USA)
William Wagner (University of Pittsburgh, USA)
Professor William R. Wagner is a Distinguished Professor of Surgery, Chemical Engineering, and Bioengineering at the University of Pittsburgh and the Founding Editor and Editor-in-Chief of one of the leading biomaterials journals, Acta Biomaterialia. He holds a B.S. (Johns Hopkins Univ.) and Ph.D. (Univ. of Texas) in chemical engineering. Professor Wagner currently serves as president of the Society for Biomaterials (US) and is a past-president of the American Society for Artificial Internal Organs (ASAIO) and past chairman of the Tissue Engineering and Regenerative Medicine International Society (TERMIS) Americas region. He is a fellow and former vice president of the American Institute for Medical and Biological Engineering (AIMBE) and has also been elected a fellow of the Biomedical Engineering Society, the International Union of Societies for Biomaterials Science and Engineering, TERMIS, the International Academy of Medical and Biological Engineering (IAMBE) and the American Heart Association. He has been selected to the “Scientific American 50”, the magazine’s annual list recognizing leaders in science and technology from the research, business and policy fields. His research has generated numerous patents (50 issued to date) and patent filings that have resulted in licensing activity, the formation of three companies, one of which initiated two clinical trials. Transfer of his group’s intellectual property has been recognized with University of Pittsburgh Innovator Awards in 2007, 2008, 2009, 2010, 2014, 2017 and 2018. Some of his awards include the Society for Biomaterials Clemson Award for Applied Research, the Chancellor’s Distinguished Research Award from the University of Pittsburgh, and the Senior Investigator Award from TERMIS-Americas. In 2017 he was inducted as a fellow of the National Academy of Inventors and in 2018 he was named Inventor of the Year by the Pittsburgh Intellectual Property Law Association. In 2019 Dr. Wagner was promoted to the rank of Distinguished Professor, the highest recognition available to University of Pittsburgh faculty. In 2020 the 4th edition of the best-selling biomaterials textbook, “Biomaterials Science” was published with Dr. Wagner taking over the lead editor role and in partnership with a new generation editorial team. He was also named by Pittsburgh Business Times to its “Power 100” list (“people who have defined and are redefining the region, and who are leading and shaping their industries”). Dr. Wagner recently received the Founder’s Award from the Society for Biomaterials (2021) and the Global Biomaterials Leadership Award from the Chinese Association for Biomaterials (2023). Dr. Wagner also was recently awarded the Marlin Mickle Outstanding Innovator Award through the University of Pittsburgh’s Innovation Institute for extraordinary commitment to innovation commercialization. Dr. Wagner’s research interests are in cardiovascular engineering with projects that address medical device biocompatibility and design, biomaterial development, and tissue engineering.
Guillermo Ameer (Northwestern University, USA)
Xuesi Chen (University of Chinese Academy of Sciences, China)
Shaoyi Jiang (Cornell University, USA)
Shaoyi Jiang (Cornell University, USA)
Shaoyi Jiang joined the Meinig School of Biomedical Engineering at Cornell as the Robert Langer ’70 Family and Friends Professor in June 2020. Before Cornell, he was the Boeing-Roundhill Professor of Engineering in the Department of Chemical Engineering and an adjunct professor of Bioengineering at the University of Washington, Seattle. He received his Ph.D. degree in chemical engineering from Cornell University in 1993. He was a postdoctoral fellow at the University of California, Berkeley between 1993 and 1994 and a research fellow at California Institute of Technology between 1994 and 1996 both in chemistry. He is currently a fellow of the American Association for the Advancement of Science (AAAS), a fellow of the American Institute of Chemical Engineers (AIChE), a fellow of the American Institute for Medical and Biological Engineering (AIMBE), an executive editor for Langmuir and an associate editor for Science Advances. He received the Braskem Award for Excellence in Materials Engineering and Science, AIChE (2017). His research focuses on biomaterials, particularly highly biocompatible and environmentally benign zwitterionic-based materials for biomedical and engineering applications.
Description
Introductory abstract of a maximum of 300 words that addresses the symposium’s
1) objectives or purposes;
2) Proposed program and intended audience
3) expected outcomes and relevance to the main topic of WBC 2024.
Keywords : Technology Translation
Session TrackWorkshop
Session TitleExplore a better future with advanced science and technology
Session CodeSP-T15-0485
Date & Time / RoomMay 28 (Tue) 16:30~18:40 / Room 211
Organizer
Xing-Jie Liang (National Center for Nanoscience and Technology of China, China)
Chair
Xing-Jie Liang (National Center for Nanoscience and Technology of China, China)
Xing-Jie Liang (National Center for Nanoscience and Technology of China, China)
Xing-Jie LIANG, Ph.D.
Member of Academia Europaea
Fellow of American Institute of Medical and Biological Engineering
Chief Professor, University of Chinese Academy of Sciences
CAS Center for Excellence in Nanoscience
CAS Key Lab of Bioeffects of Nanomaterials and Nanosafety
National Center for Nanoscience and Technology of China
E-mail: liangxj@nanoctr.cn
Tel: +86-010-82545569 Fax: +86-010-62656765
ORCID: 0000-0002-4793-1705
Dr. Xing-Jie Liang got Ph.D at National Key Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences. He finished his postdoc with Dr. Michael M. Gottesman, member of NAS and Deputy Director of NIH, for 5 years at Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health. Then, he worked as a Research Fellow at Surgical Neurology Branch, NINDS, NIH. Dr. Liang currently is a principal investigator at Center for Excellence in Nanoscience, Chinese Academy of Sciences. He as previous president of Chinese Association of Nanobiology is the Member of Academia Europaea (2023) and the elected Fellow of American Institute for Medical and Biological Engineering (AIMBE, 2020) and Faculty Member of F1000 Research (Pharmacology & Drug Delivery, 2012) and Hall of Fame (Advanced Materials, 2023). Dr. Liang has successfully developed “Injectable Nanomicelle Powder with Irinotecan” approved with CFDA and transferred NDA to pharmaceutical industry for clinical trials.
His group has published over 300 peer-reviewed articles, H-index > 100. His research interests are in elucidating mechanisms to improve drugability and nanomedicinal bioavailability by nanotechnology in vitro and in vivo, and novel strategies to increase therapeutic efficiency on cancers and infective diseases. Developing drug delivery strategies for prevention/circumvent of clinical adaptive treatment tolerance (ATT) are current programs ongoing in Professor Liang's lab based on understanding of basic physio-chemical and biological processes of nanomedicine.
Juyoung Yoon is a distinguished professor at the Department of Chemistry and Nanoscience, Ewha Womans University. He received his PhD (1994) from Ohio State University and conducted his postdoctoral work at UCLA and Scripps Research Institute. His research interests include investigations of fluorescent imaging probes, activatable photosensitizers, phototherapy and organic functional materials. His h-index is 124 and was listed as a highly cited researcher in chemistry for 2014-2023.
Guixue Wang (Bioengineering College of Chongqing University, China)
Guixue Wang (Bioengineering College of Chongqing University, China)
Dr. Guixue Wang is a Distinguished Professor of Biomedical Engineering and former Dean of the College of Bioengineering, Chongqing University, China. He also worked as the Principal Investigator of JinFeng Laboratory at Chongqing. He has also served as a Deputy Director of the Academic Committee of Chongqing University Health Science Center. He is a director of the Key Laboratory of Biorheology Science and Technology of the Chinese Ministry of Education, a founding director of the Public Experiment Center of National Biological Industrialization Base at Chongqing, and a founding director of the National Local Joint Engineering Laboratory for Vascular Implants of China, a founding director of Chongqing Engineering Laboratory for Vascular Implants of China. He serves as an Associate Editor of Research (IF:11), Deputy Editor-in-Chief of Molecular & Cellular Biomechanics, an Associate Editor of Journal of Medical and Biological Engineering, and an Editorial Member of Biomedical Materials. He also serves as a reviewer for 50 international journals.
He has served as multiple Chairpersons: including Branch of Atherosclerosis of the Chinese Society of Pathophysiology (2021.05-) and Materiobiomechanics Branch of the Chinese Society for Biomaterials (2022.12-), Honorary Chairperson: Vascular Branch of the Chinese Society of Anatomy (2023.12-), Executive Member of the Council: Interventional Treatment of Cardiac and Brain Diseases Branch of the Chinese Medical Device Industry Association (2017-), Cardiovascular Biomaterials Branch of the Chinese Society for Biomaterials (2015-), Chinese Branch of International Society of Atherosclerosis (2015-), Holistic Integrative Medicine and Engineering Alliance (2018-); Member of the Council: Chinese Society of Biomedical Engineering (2015-1019), Chinese Society for Biomaterials (2012-), Biomechanics Branch of the Chinese Society of Mechanics/Chinese Society of Biomedical Engineering (2015-), and Life Member: including World Association for Chinese Biomedical Engineers (2016-) and International Chinese Musculoskeletal Research Society (2019-).
His areas of research interest include vascular biomechanics and mechanobiology, tissue repair materials and minimally invasive interventional medical devices. He has led more than 20 national and provincial-level key scientific research projects; collaboratively published more than 300 SCI/EI indexed papers in Nat Neurosci, J Biomech, Adv Sci, Bioact Mater, Biomaterials and other academic journals; authorized more than 60 domestic and international patents; and won 6 provincial and ministerial science and technology and teaching achievement awards, 3 national industry associations and societies awards.
He was selected as the Elsevier “Most Cited Chinese Researchers in Biomedical Engineering” in 2019, 2020, 2021, 2022 and 2023; World's Top 2% Scientists in 2023; and a Fellow of International Union of Societies for Biomaterials Science and Engineering (FBSE) in 2023.
Hyung-Jun Im (Seoul National University, Korea, Republic of)
Dong Ma (Jinan University, China)
Description
Introductory abstract of a maximum of 300 words that addresses the symposium’s
1) objectives or purposes;
2) Proposed program and intended audience
3) expected outcomes and relevance to the main topic of WBC 2024.